Simplicity Solutions’s Vertex Pharmaceuticals VRTX Stock Holding History

Simplicity Solutions’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$9.27M	Buy	22,783 +4,331	+23%	+$1.6M	0.25%	70
2023 Q3	$6.42M	Sell	18,452 -12	-0.1%	-$4.2K	0.21%	92
2023 Q2	$6.5M	Buy	18,464 +9,171	+99%	+$3.09M	0.18%	105
2023 Q1	$2.93M	Buy	9,293 +5,167	+125%	+$1.55M	0.08%	232
2022 Q4	$1.19M	Sell	4,126 -255	-6%	-$77.7K	0.16%	154
2022 Q3	$1.27M	Buy	4,381 +490	+13%	+$141K	0.18%	131
2022 Q2	$1.1M	Buy	3,891 +457	+13%	+$122K	0.14%	170
2022 Q1	$897K	Buy	3,434 +1,152	+50%	+$273K	0.11%	192
2021 Q4	$502K	Buy	+2,282	New	+$444K	0.06%	391
2020 Q3	–	Sell	-1,632	Closed	-$474K	–	956
2020 Q2	$474K	Buy	+1,632	New	+$442K	0.01%	647

Other funds holding VRTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Simplicity Solutions's VRTX Position: Q4 2023 in Review

Simplicity Solutions increased its Vertex Pharmaceuticals (VRTX) stake by 23% in Q4 2023, buying an estimated $1.6M and bringing the position to 22,783 shares worth $9.27M. The position accounts for 0.25% of the portfolio, ranked #70.

Simplicity Solutions first reported a position in VRTX in Q2 2020 and has held it in 10 quarters since. 1,440 funds tracked by Wall St. Rank hold VRTX as of Q4 2023.

Simplicity Solutions held 22,783 shares of Vertex Pharmaceuticals worth $9.27M as of Q4 2023.
Simplicity Solutions bought 4,331 Vertex Pharmaceuticals shares in Q4 2023, an estimated $1.6M.
Vertex Pharmaceuticals made up 0.25% of Simplicity Solutions's portfolio in Q4 2023, its #70 holding.
Simplicity Solutions first reported a position in Vertex Pharmaceuticals in Q2 2020 and has held it in 10 quarters since.
1,440 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.